Ratos is a listed investment company that creates long-term value through active ownership, strong corporate governance and disciplined capital allocation. Here you will find information on why to invest in Ratos, our share, financial reports and presentations from our Capital Markets Days.
Latest report and presentation
Reports and presentations
Ratos: Strong quarter and execution of Ratos 2030 Strategy
Reports and presentations
Share price
37.62
SEK
The share
Latest annual report
Download report
Annual and Sustainability Report 2025
Latest press releases
Henrik Ager appointed Chairman of Diab Group
Ratos AB – change in number of shares and votes
|
Regulatory Information
Ratos AB: Strong quarter and execution of Ratos 2030 Strategy
|
Regulatory Information
Ratos CFO Anna Vilogorac takes on a new role
|
Regulatory Information
Invitation to the presentation of Ratos Interim report January-June 2026
Magnus Håkansson appointed Chairman of Kvd Group
Lisa Åberg appointed Chairman of Aleido
Ratos company HL Display has signed to acquire UFO Display Solutions
Ratos announces the sale of 9 million existing shares in Sentia ASA
Ratos Company TFS HealthScience supports trial for novel vascular therapy
Dr. Holger Rubel appointed Chairman in LEDiL
Ratos AB: Robust performance during the quarter and launch of new strategy
|
Regulatory Information
Invitation to the presentation of Ratos Interim report January-March 2026
Ratos publishes prospectus and applies for admission to trading of convertible debentures issued within the framework of its long-term incentive programs LTI 2026
|
Regulatory Information
Daniel Kjørberg Siraj appointed Chairman in Presis Infra
Comparative Figures Ahead of Ratos Q1 2026 Interim Report
Bulletin from Ratos’ AGM 25 March 2026
|
Regulatory Information
Ratos presents new strategic direction and financial targets to drive shareholder value creation
|
Regulatory Information
Ratos company HL Display completes the acquisition of Deinzer Holding GmbH
Ratos publishes Annual and Sustainability Report 2025
|
Regulatory Information
Contact Investor Relations
For questions or more information about investor relations, please do not hesitate to contact us.
